LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 117 | -33.5% | 0.00% | – |
Q2 2023 | $0 | – | 176 | +252.0% | 0.00% | – |
Q1 2023 | $0 | – | 50 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 50 | -80.2% | 0.00% | – |
Q3 2022 | $2,000 | -33.3% | 252 | -39.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 413 | -0.5% | 0.00% | – |
Q1 2022 | $4,000 | +100.0% | 415 | +91.2% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 217 | +1.9% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 213 | -15.1% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 251 | +248.6% | 0.00% | – |
Q4 2020 | $3,000 | +200.0% | 72 | +89.5% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 38 | -32.1% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 56 | -71.6% | 0.00% | – |
Q1 2020 | $1,000 | – | 197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Minerva Advisors LLC | 34,015 | $321,000 | 0.21% |
Lion Point Capital, LP | 51,205 | $481,000 | 0.11% |
Wealth Advisors of Iowa, LLC | 11,699 | $110,000 | 0.06% |
NEA Management Company, LLC | 167,608 | $1,575,000 | 0.04% |
Paladin Advisory Group, LLC | 4,382 | $40,000 | 0.03% |
Marquette Asset Management, LLC | 13,315 | $125,000 | 0.03% |
Blackstone Inc. | 468,145 | $4,401,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $450,000 | 0.01% |
Jefferies Group LLC | 120,651 | $1,134,119 | 0.01% |
Renaissance Technologies | 271,712 | $2,554,000 | 0.00% |